by GlobeNewsWire | Aug 1, 2016 | Globe Newswire
HOPKINTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory diseases, today announced...
by GlobeNewsWire | Mar 30, 2016 | Globe Newswire
LEXINGTON, Mass., March 30, 2016 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced its financial results for the year...
by GlobeNewsWire | Mar 24, 2016 | Globe Newswire
LEXINGTON, Mass., March 24, 2016 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that David J. Clark, M.D., Chief...
by GlobeNewsWire | Dec 16, 2015 | Globe Newswire
LEXINGTON, Mass., Dec. 16, 2015 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that the last patient has completed...
by GlobeNewsWire | Nov 12, 2015 | Globe Newswire
LEXINGTON, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) — Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced its financial and operating results for...